Institutions / Artia Global Partners LP
Artia Global Partners LP
CIK 1937964 · Institution · as of Dec 31, 2025
Portfolio value
$622.42M
Positions
50
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 50 →
| Company | Value | % of portfolio |
|---|---|---|
| Insmed Inc | $118.73M | 19.1% |
| Abivax SA | $81.01M | 13.0% |
| Argenx SE | $54.41M | 8.7% |
| ELI LILLY & Co | $54.27M | 8.7% |
| Viking Therapeutics Inc | $25.31M | 4.1% |
| Trevi Therapeutics, Inc. | $25.21M | 4.1% |
| Soleno Therapeutics, Inc. | $24.71M | 4.0% |
| ProShares Tr II | $24.55M | 3.9% |
| Uniqure NV | $24.49M | 3.9% |
| Newamsterdam Pharma Company | $17.68M | 2.8% |
| Astrazeneca PLC | $17.54M | 2.8% |
| Cidara Therapeutics Inc | $15.64M | 2.5% |
| EyePoint, Inc. | $14.01M | 2.3% |
| Ionis Pharmaceuticals Inc | $11.42M | 1.8% |
| Dianthus Therapeutics, Inc. | $8.45M | 1.4% |
| Revolution Medicines, Inc. | $8.30M | 1.3% |
| Quest Diagnostics Inc | $7.08M | 1.1% |
| Alnylam Pharmaceuticals Inc | $6.92M | 1.1% |
| Ventyx Biosciences, Inc. | $6.28M | 1.0% |
| Palvella Therapeutics, Inc.PVLA | $6.20M | 1.0% |
| Mineralys Therapeutics IncMLYS | $5.00M | 0.8% |
| Sionna Therapeutics, Inc. | $4.93M | 0.8% |
| Palisade Bio, Inc. | $4.68M | 0.8% |
| Avidity Biosciences, Inc. | $4.34M | 0.7% |
| Scholar Rock Holding Corp | $4.24M | 0.7% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.